Add
STRM to Portfolio
Set Alert
Email to a
Friend
| |||
|
|
Quotes & Info
|
| STRM > SEC Filings for STRM > Form 8-K on 1-Nov-2012 | All Recent SEC Filings |
1-Nov-2012
Unregistered Sale of Equity Securities, Material Modification to
On November 1, 2012, the Convertible Subordinated Notes previously issued by Streamline Health Solutions, Inc. (the "Company") on August 16, 2012 were converted into shares of the Company's Series A 0% Convertible Preferred Stock (the "Preferred Stock"). The Convertible Subordinated Notes had an aggregate principal amount of $5,699,577.04 and converted into an aggregate of 1,583,210 shares of Preferred Stock. The issuance of the Convertible Subordinated Notes was previously disclosed in the Current Report on Form 8-K filed on August 21, 2012, and the form of Convertible Note containing the conversion terms was filed as Exhibit 10.5 to that Form 8-K.
On October 31, 2012, the Company filed a Certificate of Correction with the State of Delaware regarding the Certificate of Designation of Preferences, Rights and Limitations of Series A 0% Convertible Preferred Stock, which was previously filed as Exhibit 10.8 to Form 8-K filed on August 21, 2012. The corrected Certificate of Designation of Preferences, Rights and Limitations of Series A 0% Convertible Preferred Stock is attached as Exhibit 10.1 to this Current Report on Form 8-K.
On October 31, 2012, the Company held a special meeting of stockholders (the
"Special Meeting"). At the Special Meeting, the stockholders voted on:
(1) approval of the issuance of more than 20% of the Company's common stock at a
discount greater to the book or market value pursuant to conversion of the
Subordinated Convertible Notes and anti-dilution provisions of warrants; and
(2) approval to amend the 2005 Incentive Compensation Plan to increase the
amount of shares by 500,000.
As to the approval of the issuance of more than 20% of the Company's common stock, the Company's stockholders approved the proposal by a vote of 7,378,906 shares FOR, 120,954 shares AGAINST, and 13,050 shares ABSTAINED.
As to the proposal to increase the number of shares under the 2005 Incentive Compensation Plan, the Company's stockholders approved the proposal by a vote of 8,960,280 shares FOR, 328,351 shares AGAINST, and 22,950 shares ABSTAINED.
Item 9.01 - Exhibits.
(d) Exhibits
10.1 Corrected Certificate of Designation of Preferences, Rights and Limitations of Series A 0% Convertible Preferred Stock
|
|